Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2014
07/30/2014CN101218348B 具有提高的同源重组效率的丝状真菌突变体 Filamentous fungi with improved efficiency for homologous recombination mutants
07/30/2014CN101014705B 改进的酶 Improved enzyme
07/29/2014US8791346 Variety corn line NPID3649
07/29/2014US8791344 Maize variety inbred PH13JD
07/29/2014US8791342 Soybean cultivar 21202
07/29/2014US8791341 Soybean cultivar 20895
07/29/2014US8791340 Soybean cultivar 76983
07/29/2014US8791339 Soybean cultivar WN0912883
07/29/2014US8791338 Soybean cultivar BY0912810
07/29/2014US8791337 Soybean cultivar BY0811023
07/29/2014US8791336 Soybean cultivar OW1012932
07/29/2014US8791335 Soybean cultivar WN0913535
07/29/2014US8791334 Soybean variety XB26W12
07/29/2014US8791333 Soybean variety 20872NNR2Y
07/29/2014US8791332 Lettuce variety carini (LS9499)
07/29/2014US8791331 Spinach hybrid RX 06692157
07/29/2014US8791330 Expression regulatory elements
07/29/2014US8791329 Reducing levels of nicotinic alkaloids in plants
07/29/2014US8791328 Polypeptides having endoglucanase activity and polynucleotides encoding same
07/29/2014US8791327 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
07/29/2014US8791326 AXMI-150 delta-endotoxin gene and methods for its use
07/29/2014US8791325 Chloroplast transit peptides for efficient targeting of DMO and uses thereof
07/29/2014US8791324 Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
07/29/2014US8791323 Hybrid antibodies comprising human variable regions and mouse constant regions produced in a genetically modified mouse
07/29/2014US8791250 Compositions and methods for inhibiting expression of the HAMP gene
07/29/2014US8791249 Nucleic acid encoding humanized c-kit antibody
07/29/2014US8791247 Recombinant expression vector system for variants of coagulation factor VIII and von willebrand factor
07/29/2014US8791238 Artificial binding proteins based on ubiquitin
07/29/2014US8791088 Compositions and methods for modulation of LMNA expression
07/29/2014US8791087 Treatment of ‘C terminus of HSP70-interacting protein’ (CHIP)related diseases by inhibition of natural antisense transcript to CHIP
07/29/2014US8791086 Polyion complex comprising PHD2 expression inhibiting substance
07/29/2014US8791083 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry
07/29/2014US8791082 Double-stranded and single-stranded RNA molecules with 5′ triphosphates and their use for inducing interferon
07/29/2014US8791068 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
07/29/2014US8791062 Skin permeating and cell entering (SPACE) peptides and methods of use thereof
07/29/2014US8790928 Utilisation of constructs comprising recombination sequence motifs for enhancing gene expression in moss
07/29/2014US8790924 Reversible platelet inhibition
07/29/2014US8790922 RNA sequence-specific mediators of RNA interference
07/29/2014US8790919 Compositions and methods for optimizing cleavage of RNA by RNase H
07/29/2014US8790911 Increased ethanol production by genetic engineering of microorganisms to express hemoglobin
07/29/2014US8790910 Live vaccine strain
07/29/2014US8790906 Lysophospholipid acyltransferase
07/29/2014US8790905 Fructosyl peptide oxidase
07/29/2014US8790903 Metabolic engineering of xylose-fermenting eukaryotic cells
07/29/2014US8790902 Microorganisms having enhanced tolerance to inhibitors and stress
07/29/2014US8790900 Microorganisms having enhanced sucrose mutase activity
07/29/2014US8790898 Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodies
07/29/2014US8790895 Generation of artificial binding proteins on the basis of ubiquitin proteins
07/29/2014US8790883 Methods of identifying NF-κB inhibitors
07/29/2014US8790876 Methods of amplifying and sequencing nucleic acids
07/29/2014US8790870 Quantitative HIV phenotype or tropism assay
07/29/2014US8790663 Antigenic determinants of human death receptor DR5
07/29/2014US8790656 PRRSV vaccines
07/29/2014US8790648 Methods of treating psoriasis using IL-17 receptor A antibodies
07/29/2014US8790641 Production of high mannose proteins in plant culture and therapeutic uses thereof
07/29/2014US8790639 Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin
07/29/2014US8790636 Human skin equivalents expressing exogenous polypeptides
07/29/2014US8790635 Live, oral vaccine for protection against Shigella dysenteriae serotype 1
07/29/2014CA2718812C Porcine adenovirus type 3 genome
07/29/2014CA2718652C Process for producing ubiquinone-10
07/29/2014CA2703147C Plant diacylglycerol acyltransferases
07/29/2014CA2691033C Capsid proteins and uses therefore
07/29/2014CA2690475C Promoter
07/29/2014CA2685270C Expression vectors for stimulating an immune response and methods of using the same
07/29/2014CA2602689C Development of a real-time pcr assay for detection of pneumococcal dna and diagnosis of pneumococcal disease
07/29/2014CA2592249C Binding proteins specific for human matriptase
07/29/2014CA2589487C Means and methods for detecting methylated dna
07/29/2014CA2570812C Brassica indehiscent1 sequences
07/29/2014CA2568781C Intrathymic administration of viral vectors for the induction of immune tolerance, the prevention or treatment of immunodeficiencies or autoimmune diseases
07/29/2014CA2567109C Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities
07/29/2014CA2549386C Methods for synthesis of encoded libraries
07/29/2014CA2547043C A plasma source and applications thereof
07/29/2014CA2494974C Il-7 drug substance, composition, preparation and uses
07/29/2014CA2489052C Infectious cdna of an approved vaccine strain of measles virus, use for immunogenic compositions
07/29/2014CA2486658C Method for efficient rna interference in mammalian cells
07/29/2014CA2486104C Tri-block polymers for nanosphere-based drug or gene delivery
07/29/2014CA2463772C Thrombin-cleavable chimeric proteins
07/29/2014CA2455365C Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
07/29/2014CA2411304C Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level
07/29/2014CA2408406C Cutinase variants
07/24/2014WO2014113759A1 Theragnostic particles
07/24/2014WO2014113738A1 Compositions and methods for identifying enzyme modulators or inhibitors
07/24/2014WO2014113668A1 Mirna targets
07/24/2014WO2014113605A1 Proteins involved in plant stress response
07/24/2014WO2014113585A1 Split peroxidases and methods of use
07/24/2014WO2014113541A1 Attenuated chlamydia vaccine
07/24/2014WO2014113540A1 A deep intronic target for splicing correction on spinal muscular atrophy gene
07/24/2014WO2014113493A1 Cas9-nucleic acid complexes and uses related thereto
07/24/2014WO2014113436A1 Adenoviruses and their use
07/24/2014WO2014113089A2 Signal-sensor polynucleotides for the alteration of cellular phenotypes
07/24/2014WO2014112997A1 Treatment of crops with a lower alkyl naphthalene to alter cell cycle and water regulation
07/24/2014WO2014112875A1 A new method to provide resistance to bacterial soft rot in plants
07/24/2014WO2014111876A2 Modulation of mitophagy and use thereof
07/24/2014WO2014111858A1 Artificial dna sequence with optimized leader function in 5' (5'-utr) for the over-expression of recombinant proteins in plants and method for the production of recombinant proteins in plants
07/24/2014WO2014111724A1 Glycosylation method
07/24/2014WO2014110675A1 Novel cell wall deconstruction enzymes of amorphotheca resinae, rhizomucor pusillus, and calcarisporiella thermophila, and uses thereof
07/24/2014WO2014110628A1 Gene and mutations thereof associated with seizure disorders
07/24/2014WO2014093635A9 Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
07/24/2014WO2014068438A3 Novel acyltransferase polynucleotides, polypeptides, and methods of use
07/24/2014WO2014057432A3 Multicomponent lipid nanoparticles and processes for the preparation thereof
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 4023